Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
27
HHS Quote, Financials, Valuation and Earnings
Last price:
$5.35
Seasonality move
:
5.28%
Day range:
$5.26 - $5.42
52-week range:
$5.26 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.21x
P/B ratio:
1.84x
Volume:
6.4K
Avg. volume:
22.5K
1-year change:
-24.39%
Market cap:
$38.6M
Revenue:
$191.5M
EPS (TTM):
-$4.11
Analysts' Opinion
-
Consensus RatingHarte-Hanks has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Harte-Hanks has an estimated upside of 230.19% from its current price of $5.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $5.30.
Fair Value
-
According to the consensus of 0 analysts, Harte-Hanks has 230.19% upside to fair value with a price target of -- per share.
HHS vs. S&P 500
-
Over the past 5 trading days, Harte-Hanks has underperformed the S&P 500 by -7.07% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Harte-Hanks does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Harte-Hanks has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Harte-Hanks reported revenues of $47.6M.
Earnings Growth
-
Harte-Hanks earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported earnings per share of $0.02.
Enterprise value:
32.7M
EV / Invested capital:
1.55x
Price / LTM sales:
0.21x
EV / EBIT:
4.24x
EV / Revenue:
0.17x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.59x
Price / Operating cash flow:
165.56x
Enterprise value / EBITDA:
2.72x
Gross Profit (TTM):
$129.3M
Return On Assets:
-26.41%
Net Income Margin (TTM):
-15.91%
Return On Equity:
-146.3%
Return On Invested Capital:
-146.3%
Operating Margin:
5.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $203.5M | $196.8M | $187.6M | $47.1M | $47.6M | |
| Gross Profit | $146.7M | $134.1M | $129.3M | $31.7M | $33.2M | |
| Operating Income | $16M | $9.1M | $9.2M | $2.9M | $2.7M | |
| EBITDA | $22.2M | $7.1M | $12M | $3.9M | $3.8M | |
| Diluted EPS | $1.94 | $3.07 | -$4.11 | $0.08 | $0.02 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $91.6M | $82.5M | $80.6M | $62.2M | $53.8M | |
| Total Assets | $114.7M | $112.5M | $111.1M | $110.8M | $108.1M | |
| Current Liabilities | $50M | $42.4M | $45.8M | $38.7M | $36.9M | |
| Total Liabilities | $153.9M | $141.1M | $114.2M | $90.3M | $87.1M | |
| Total Equity | -$39.2M | -$28.7M | -$3.1M | $20.5M | $21M | |
| Total Debt | $27.1M | $13.1M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26.4M | $12.7M | -$2.7M | $1.5M | -$2.9M | |
| Cash From Investing | -$6.2M | -$7.3M | -$4M | -$222K | -$1.9M | |
| Cash From Financing | -$15M | -$12.5M | -$411K | -$818K | -$163K | |
| Free Cash Flow | $20.1M | $11.1M | -$7.1M | $1.3M | -$4.9M | |
HHS
Sector
Market Cap
$38.6M
$110M
Price % of 52-Week High
59.75%
66.37%
Dividend Yield
0%
0%
Shareholder Yield
0.57%
3.39%
1-Year Price Total Return
-24.39%
-16.31%
Beta (5-Year)
0.561
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$5.50
200-day SMA
Sell
Level
$7.26
Bollinger Bands (100)
Sell
Level
6.15 - 7.69
Chaikin Money Flow
Sell
Level
-7.6M
20-day SMA
Sell
Level
$5.65
Relative Strength Index (RSI14)
Sell
Level
31.39
ADX Line
Sell
Level
15.35
Williams %R
Buy
Level
-95.7447
50-day SMA
Sell
Level
$6.39
MACD (12, 26)
Sell
Level
-0.27
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-18.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.8923)
Sell
CA Score
(Annual)
Level (-1.0733)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-9.3126)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Stock Forecast FAQ
In the current month, HHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HHS average analyst price target in the past 3 months is --.
-
Where Will Harte-Hanks Stock Be In 1 Year?
According to analysts, the consensus estimate is that Harte-Hanks share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Harte-Hanks?
Analysts are divided on their view about Harte-Hanks share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Harte-Hanks is a Sell and believe this share price will drop from its current level to --.
-
What Is Harte-Hanks's Price Target?
The price target for Harte-Hanks over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Harte-Hanks is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HHS?
You can purchase shares of Harte-Hanks via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Harte-Hanks shares.
-
What Is The Harte-Hanks Share Price Today?
Harte-Hanks was last trading at $5.35 per share. This represents the most recent stock quote for Harte-Hanks. Yesterday, Harte-Hanks closed at $5.30 per share.
-
How To Buy Harte-Hanks Stock Online?
In order to purchase Harte-Hanks stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
